Merck & Co. stock was EUR 130.41 on October 9, 2026, up 3.07 percent from EUR 126.52. Third-quarter

Wedmont Private Capital increased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 39.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 39,432 shares of the company

Brown Shipley& Co Ltd decreased its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 20.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,398 shares of the company

Douglas Lane & Associates LLC trimmed its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 3.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 532,699 shares of the company

Cantor raised its target from USD 120.00 to USD 145.00 on October 8, 2026. Merck stock costs EUR 127

Mn Services Vermogensbeheer B.V. lifted its stake in Merck & Co., Inc. (NYSE:MRK - Free Report) by 1.5% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 730,921 shares of the company

Farther Finance Advisors LLC boosted its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 9.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 132,641 shares of the company

Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of Merck & Co., Inc. (NYSE:MRK). In a filing disclosed on October 7th, the Representative disclosed that they had sold between $1,001 and $15,000 in Merck & Co., Inc. stock on September 24th. The trade occurred in the Repr

Cantor lifted its target to USD 145.00 on October 8, 2026. Merck & Co. stock was EUR 125.51 on Octob

Quintet Private Bank Europe S.A. boosted its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 19.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 337,040 shares of the company

Masterson receives 2026 Mentor of the Year honors from Merck Animal Health and American Association of Bovine Practitioners.

Cantor Fitzgerald lifted their price objective on Merck & Co., Inc. from $120.00 to $145.00 and gave the stock a "neutral" rating in a report on Thursday.

Congress Asset Management Co. boosted its holdings in Merck & Co., Inc. (NYSE:MRK - Free Report) by 238.9% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 18,204 shares of the company

Canandaigua National Trust Co of Florida purchased a new position in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 11,515 shares of the company

Canandaigua National Bank & Trust Co. lessened its holdings in shares of Merck & Co., Inc. (NYSE:MRK - Free Report) by 16.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 70,117 shares of the company